Summary of Study ST001074

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000719. The data can be accessed directly via it's Project DOI: 10.21228/M8R38S This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files
Study IDST001074
Study TitleOpen source discovery of starting points for next generation chemoprotective antimalarial drugs (Biofocus 1)
Study TypeDrug Exposure
Study SummaryMetabolic examination/confirmation of resistance mutations observed in study
Institute
Pennsylvania State University
DepartmentBMB
LaboratoryLlinás
Last NameOwen
First NameEdward
AddressW-122 Millennium Science Complex, Pollock Road, University Park, PA 16802
Emaileso5005@psu.edu
Phone(814) 867-3527
Submit Date2018-02-15
Analysis Type DetailLC-MS
Release Date2018-10-16
Release Version1
Edward Owen Edward Owen
https://dx.doi.org/10.21228/M8R38S
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR000719
Project DOI:doi: 10.21228/M8R38S
Project Title:Open source discovery of starting points for next generation chemoprotective antimalarial drugs (Biofocus 1)
Project Type:LC-MS Metabolomics
Project Summary:Hydrophilic LC-MS analysis of Biofocus 1 compounds as part of functional validation of publication.
Institute:Pennsylvania State University
Department:BMB
Laboratory:Llinás Laboratory
Last Name:Owen
First Name:Edward
Address:W-122 Millennium Science Complex, Pollock Road, University Park, PA 16802
Email:eso5005@psu.edu
Phone:Lab: (814) 867-3527
Funding Source:Bill & Melinda Gates Foundation
Project Comments:RAW files not submitted as untargeted analysis likely ongoing following publication
  logo